Psychosocial interventions for people with both severe mental illness and substance misuse
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Even low levels of substance misuse by people with a severe mental illness can have detrimental effects. OBJECTIVES: To assess the effects of psychosocial interventions for reduction in substance use in people with a serious mental illness compared with standard care. SEARCH METHODS: For this update (2013), the Trials Search Co-ordinator of the Cochrane Schizophrenia Group (CSG) searched the CSG Trials Register (July 2012), which is based on regular searches of major medical and scientific databases. The principal authors conducted two further searches (8 October 2012 and 15 January 2013) of the Cochrane Database of Systematic Reviews, MEDLINE and PsycINFO. A separate search for trials of contingency management was completed as this was an additional intervention category for this update. SELECTION CRITERIA: We included all randomised controlled trials (RCTs) comparing psychosocial interventions for substance misuse with standard care in people with serious mental illness. DATA COLLECTION AND ANALYSIS: We independently selected studies, extracted data and appraised study quality. For binary outcomes, we calculated standard estimates of relative risk (RR) and their 95% confidence intervals (CI) on an intention-to-treat basis. For continuous outcomes, we calculated the mean difference (MD) between groups. For all meta-analyses we pooled data using a random-effects model. Using the GRADE approach, we identified seven patient-centred outcomes and assessed the quality of evidence for these within each comparison. MAIN RESULTS: We included 32 trials with a total of 3165 participants. Evaluation of long-term integrated care included four RCTs (n = 735). We found no significant differences on loss to treatment (n = 603, 3 RCTs, RR 1.09 CI 0.82 to 1.45, low quality of evidence), death by 3 years (n = 421, 2 RCTs, RR 1.18 CI 0.39 to 3.57, low quality of evidence), alcohol use (not in remission at 36 months) (n = 143, 1 RCT, RR 1.15 CI 0.84 to 1.56,low quality of evidence), substance use (n = 85, 1 RCT, RR 0.89 CI 0.63 to 1.25, low quality of evidence), global assessment of functioning (n = 171, 1 RCT, MD 0.7 CI 2.07 to 3.47, low quality of evidence), or general life satisfaction (n = 372, 2 RCTs, MD 0.02 higher CI 0.28 to 0.32, moderate quality of evidence).For evaluation of non-integrated intensive case management with usual treatment (4 RCTs, n = 163) we found no statistically significant difference for loss to treatment at 12 months (n = 134, 3 RCTs, RR 1.21 CI 0.73 to 1.99, very low quality of evidence).Motivational interviewing plus cognitive behavioural therapy compared to usual treatment (7 RCTs, total n = 878) did not reveal any advantage for retaining participants at 12 months (n = 327, 1 RCT, RR 0.99 CI 0.62 to 1.59, low quality of evidence) or for death (n = 493, 3 RCTs, RR 0.72 CI 0.22 to 2.41, low quality of evidence), and no benefit for reducing substance use (n = 119, 1 RCT, MD 0.19 CI -0.22 to 0.6, low quality of evidence), relapse (n = 36, 1 RCT, RR 0.5 CI 0.24 to 1.04, very low quality of evidence) or global functioning (n = 445, 4 RCTs, MD 1.24 CI 1.86 to 4.34, very low quality of evidence).Cognitive behavioural therapy alone compared with usual treatment (2 RCTs, n = 152) showed no significant difference for losses from treatment at 3 months (n = 152, 2 RCTs, RR 1.12 CI 0.44 to 2.86, low quality of evidence). No benefits were observed on measures of lessening cannabis use at 6 months (n = 47, 1 RCT, RR 1.30 CI 0.79 to 2.15, very low quality of evidence) or mental state (n = 105, 1 RCT, Brief Psychiatric Rating Scale MD 0.52 CI -0.78 to 1.82, low quality of evidence).We found no advantage for motivational interviewing alone compared with usual treatment (8 RCTs, n = 509) in reducing losses to treatment at 6 months (n = 62, 1 RCT, RR 1.71 CI 0.63 to 4.64, very low quality of evidence), although significantly more participants in the motivational interviewing group reported for their first aftercare appointment (n = 93, 1 RCT, RR 0.69 CI 0.53 to 0.9). Some differences, favouring treatment, were observed in abstaining from alcohol (n = 28, 1 RCT, RR 0.36 CI 0.17 to 0.75, very low quality of evidence) but not other substances (n = 89, 1 RCT, RR -0.07 CI -0.56 to 0.42, very low quality of evidence), and no differences were observed in mental state (n = 30, 1 RCT, MD 0.19 CI -0.59 to 0.21, very low quality of evidence).We found no significant differences for skills training in the numbers lost to treatment by 12 months (n = 94, 2 RCTs, RR 0.70 CI 0.44 to 1.1, very low quality of evidence).We found no differences for contingency management compared with usual treatment (2 RCTs, n = 206) in numbers lost to treatment at 3 months (n = 176, 1 RCT, RR 1.65 CI 1.18 to 2.31, low quality of evidence), number of stimulant positive urine tests at 6 months (n = 176, 1 RCT, RR 0.83 CI 0.65 to 1.06, low quality of evidence) or hospitalisations (n = 176, 1 RCT, RR 0.21 CI 0.05 to 0.93, low quality of eviden
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744
The brief symptom inventory: an introductory report.
Derogatis, L. R., & Melisaratos, N. (1983) · Psychological Medicine · doi:10.1017/s0033291700048017 · Cited by 6,650
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
The Global Assessment Scale: A Procedure for Measuring Overall Severity of Psychiatric Disturbance
Endicott, J. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770060086012 · Cited by 4,982
Skevington, S. M., Lotfy, M., & O'Connell, K. A. (2004) · Quality of Life Research · doi:10.1023/b:qure.0000018486.91360.00 · Cited by 4,686
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Moher, D., Pham, B., Jones, A., Cook, D. J., Jadad, A. R., Moher, M., Tugwell, P., & Klassen, T. P. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01085-x · Cited by 3,560
Improving the Quality of Reporting of Randomized Controlled Trials: The CONSORT Statement
Begg, C. (1996) · JAMA · doi:10.1001/jama.1996.03540080059030 · Cited by 3,127
Assessment of client/patient satisfaction: development of a general scale
Larsen, D. L., Attkisson, C. C., Hargreaves, W. A., & Nguyen, T. D. (1979) · Evaluation and Program Planning · doi:10.1016/0149-7189(79)90094-6 · Cited by 2,887
SCAN: Schedules fonr Clinical Assessment in Neuropsychiatry
Wing, J. K. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810180089012 · Cited by 2,517
Research works printed but not linked: 272
- Baker, 2002, Evaluation of a motivational interview for substance use within psychiatric inpatient services, Addiction, 97, 1329, 10.1046/j.1360-0443.2002.00178.x · DOI · Paper page
- Baker, 2002, Motivational interviewing among psychiatric inpatients with substance use disorders, Acta Psychiatrica Scandinavica, 106, 233, 10.1034/j.1600-0447.2002.01118.x · DOI · Paper page
- Baker, 2004, Intervention for alcohol, cannabis and amphetamine use among people with a psychotic illness, 1
- Baker, 2005, Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies, Psychiatry Research, 134, 241, 10.1016/j.psychres.2005.02.006 · DOI
- Barrowclough, 2001, Randomized controlled trial of motivational interviewing, cognitive behavior therapy and family intervention for patients with comorbid schizophrenia and substance use disorders, American Journal of Psychiatry, 158, 1706, 10.1176/appi.ajp.158.10.1706 · DOI · Paper page
- Haddock, 2003, Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18-month outcomes of a randomised controlled trial, British Journal of Psychiatry, 183, 418, 10.1192/bjp.183.5.418 · DOI · Paper page
- Barrowclough, 2011, A randomized controlled trial of integrated motivational interviewing and cognitive behavior therapy (mi-cbt) for people with a schizophrenia diagnosis and substance misuse - the MIDAS trial, Schizophrenia Bulletin, 37 Suppl 1, 295
- Barrowclough, 2006, Treatment development for psychosis and co-occurring substance misuse: a descriptive review, Journal of Mental Health, 15, 619, 10.1080/09638230600998920 · DOI
- Barrowclough, 2010, Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial, BMJ, 341, 6325, 10.1136/bmj.c6325 · DOI · Paper page
- Barrowclough, 2010, Predicting therapeutic alliance in clients with psychosis and substance misuse, Journal of Nervous and Mental Disease, 198, 373, 10.1097/NMD.0b013e3181da4d4e · DOI · Paper page
- Haddock, 2012, Assessing fidelity to integrated motivational interviewing and CBT therapy for psychosis and substance use: the MI-CBT fidelity scale (MI-CTS), Journal of Mental Health 2012;21(1):38-48, 21, 38
- Hartley, 2012, Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: A study using data from a randomised controlled trial, Behaviour Research and Therapy, 50, 65, 10.1016/j.brat.2011.10.007 · DOI
- Shabaruddin, 2011, Cost of delivering psychiatric inpatient care to mental health patients with psychosis and co-occuring substance use: A UK based study, Value in Health, 14, A291, 10.1016/j.jval.2011.08.327 · DOI
- Bechdolf, 2011, State-dependent motivational interviewing for people with schizophrenia and substance use : Results of a randomised controlled trial, Nervenarzt, 83, 888, 10.1007/s00115-011-3331-6 · DOI
- Bellack, 2006, A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental iIlness, Archives of General Psychiatry, 63, 426, 10.1001/archpsyc.63.4.426 · DOI · Paper page
- Brown, 2011, Predictors of initiation and engagement in substance abuse treatment among individuals with co-occurring serious mental illness and substance use disorders, Addictive Behaviors, 36, 439, 10.1016/j.addbeh.2010.12.001 · DOI · Paper page
- Bond, 1991, Assertive community treatment and reference groups: an evaluation of their effectiveness for young adults with serious mental illness and substance abuse problems, Psychosocial Rehabilitation Journal, 15, 31, 10.1037/h0095785 · DOI
- Bond, 1991, Assertive community treatment and reference groups: an evaluation of their effectiveness for young adults with serious mental illness and substance abuse problems, Psychosocial Rehabilitation Journal, 15, 31, 10.1037/h0095785 · DOI
- Bonsack, 2010, Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial, Early Intervention in Psychiatry, 4 Suppl 1, 159
- Bonsack, 2011, Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial, Psychotherapy and Psychosomatics, 80, 287, 10.1159/000323466 · DOI · Paper page
- Burnam, 1995, An experimental evaluation of residential and nonresidential treatment for dually diagnosed homeless adults, Journal of Addictive Diseases, 14, 111, 10.1300/J069v14n04_07 · DOI · Paper page
- McGlynn, 1993, Treatment for the dually diagnosed homeless: program models and implementation experience: Los Angeles, Alcohol Treatment Quarterly, 10, 171, 10.1300/J020V10N03_14 · DOI
- Chandler, 2006, Integrated treatment for jail recidivists with co-occurring psychiatric and substance use disorders, Community Mental Health Journal, 42, 405, 10.1007/s10597-006-9055-6 · DOI
- Drake, 2006, The challenge of treating forensic dual diagnosis clients: comment on "Integrated treatment for jail recidivists with co-occurring psychiatric and substance use disorders", Community Mental Health Journal, 42, 427, 10.1007/s10597-006-9045-8 · DOI
- Clark, 1998, Cost-effectiveness of assertive community treatment versus standard case management for persons with co-occurring severe mental illness and substance use disorders, Health Services Research, 33, 1285
- Drake, 1998, Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: a clinical trial, American Journal of Orthopsychiatry, 68, 201, 10.1037/h0080330 · DOI · Paper page
- Edwards, 2006, Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis, Acta Psychiatrica Scandinavica, 114, 109, 10.1111/j.1600-0447.2006.00783.x · DOI · Paper page
- Essock, 2006, Comparison of ACT and Standard Case Management for Delivering Integrated Treatment for Co-occurring Disorders, Psychiatric Services, 57, 185, 10.1176/appi.ps.57.2.185 · DOI · Paper page
- Kanter J Clinical case management, case management and ACT Psychiatric Services 2006 578 · DOI
- Manuel, 2009, A longitudinal analysis of psychiatric medication adherence and provider continuity among individuals with co-occurring disorders, Dissertation Abstracts International Section A: Humanities and Social Sciences, 69, 4126
- Manuel, 2011, Does assertive community treatment increase medication adherence for people with co-occurring psychotic and substance use disorders?, Journal of the American Psychiatric Nurses Association, 17, 51, 10.1177/1078390310395586 · DOI · Paper page
- Godley, 1994, Final MISA Report
- Graeber, 2003, A pilot study comparing motivational interviewing and an educational intervention in patients with schizophrenia and alcohol use disorders, Community Mental Health Journal, 39, 189, 10.1023/A:1023371705506 · DOI
- Hellerstein, 1995, A prospective study of integrated outpatient treatment for substance-abusing schizophrenic patients, American Journal on Addictions, 4, 33, 10.1111/j.1521-0391.1995.tb00256.x · DOI · Paper page
- Hellerstein, 2001, Integrating services for schizophrenia and substance abuse, Psychiatric Quarterly, 72, 291, 10.1023/A:1010385114289 · DOI
- Hickman ME The effects of personal feedback on alcohol intake in dually diagnosed clients: an empirical study of William R. Miller's motivational enhancement therapy Unpublished thesis. University Graduate School, Dept. Counseling Psychology, Indiana University 1997
- Fohlmann, 2010, CapOpus. randomized clinical trial: Specialized addiction treatment (MI & CBT) versus treatment as usual for young patients with cannabis abuse and psychosis, Early Intervention in Psychiatry, 4 Suppl 1, 159
- Fohlmann, 2010, CapOpus. randomized clinical trial: Specialized addiction treatment (MI & CBT) versus treatment as usual for young patients with cannabis abuse and psychosis, Early Intervention in Psychiatry, 4 Suppl 1, 160
- Hjorthaj, 2010, Validity of self-reported cannabis use as measured by the timeline follow-back instrument in a trial randomizing people with comorbid cannabis use disorder and schizophrenia spectrum disorder, Early Intervention in Psychiatry, 4 Suppl 1, 160
- Hjorthoj, 2008, Design paper: the CapOpus trial: a randomized, parallel-group, observer-blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis, Trials, 9, 42, 10.1186/1745-6215-9-42 · DOI
- Hjorthoj, 2010, Interim analysis of the CapOpus trial: a randomized, parallel-group, observer-blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis, Schizophrenia Research, 117, 190, 10.1016/j.schres.2010.02.245 · DOI
- Hjorthoj, 2011, Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (tlfb)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial, Addiction, 107, 1123, 10.1111/j.1360-0443.2011.03757.x · DOI · Paper page
- Hjorthoj, 2013, Test-retest reliability of the Danish adult reading test in patients with comorbid psychosis and cannabis-use disorder, Nordic Journal of Psychiatry, 67, 159, 10.3109/08039488.2012.691544 · DOI
- Hjorthøj, 2013, Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial, Psychological Medicine, 43, 1499, 10.1017/S0033291712002255 · DOI · Paper page
- Nordentoft, 2009, Capopus trial: An observer-blinded rct of specialized addiction treatment versus standard treatment for young patients with cannabis, Proceedings of the 17th European Psychiatric Association, EPA Congress; 2009 Jan 24-28; Lisbon Portugal, 24, S1178
- Jerrell, 1996, Cost-effective treatment for persons with dual disorders, New Directions for Mental Health Services, 70, 79, 10.1002/yd.23319960208 · DOI
- Jerrell, 1994, Cost-effectiveness of substance disorder interventions for people with severe mental illness, Journal of Mental Health Administration, 21, 283, 10.1007/BF02521335 · DOI
- Jerrell, 1995, Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders, Journal of Nervous and Mental Disease, 183, 566, 10.1097/00005053-199509000-00002 · DOI · Paper page
- Jerrell, 1999, Impact of robustness of program implementation on outcomes of clients in dual diagnosis programs, Psychiatric Services, 50, 109, 10.1176/ps.50.1.109 · DOI · Paper page
- Jerrell, 1995, Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders, Journal of Nervous and Mental Disease, 183, 566, 10.1097/00005053-199509000-00002 · DOI · Paper page
- Kemp, 2007, Stop using stuff: trial of a drug and alcohol intervention for young people with comorbid mental illness and drug and alcohol problems, Australasian Psychiatry, 15, 490, 10.1080/10398560701439665 · DOI
- Lehman, 1993, Rehabilitation for adults with severe mental illness and substance use disorders: a clinical trial, Journal of Nervous and Mental Disease, 181, 86, 10.1097/00005053-199302000-00003 · DOI · Paper page
- Madigan, 2013, A multi-center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness, Schizophrenia Research, 143, 138, 10.1016/j.schres.2012.10.018 · DOI
- McDonell, 2013, Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness, American Journal of Psychiatry, 170, 94, 10.1176/appi.ajp.2012.11121831 · DOI · Paper page
- Weiss, 2013, Contingency management for patients with serious mental illness and stimulant dependence, American Journal of Psychiatry, 170, 6, 10.1176/appi.ajp.2012.12101324 · DOI
- Calsyn, 2005, Impact of assertive community treatment and client characteristics on criminal justice outcomes in dual disorder homeless individuals, Criminal Behaviour and Mental Health, 15, 236, 10.1002/cbm.24 · DOI · Paper page
- Fletcher, 2008, Evaluation of treatment programs for dual disorder individuals: modeling longitudinal and mediation effects, Administration and Policy in Mental Health, 35, 319, 10.1007/s10488-008-0170-2 · DOI
- Morse, 2008, Integrated treatment for homeless clients with dual disorders: a quasi-experimental evaluation, Journal of Dual Diagnosis, 4, 219, 10.1080/15504260802072065 · DOI
- Morse, 2006, Treating homeless clients with severe mental illness and substance use disorders: costs and outcomes, Community Mental Health Journal, 42, 377, 10.1007/s10597-006-9050-y · DOI
- Naeem, 2005, Cognitive behaviour therapy for schizophrenia in patients with mild to moderate substance misuse problems, Cognitive Behaviour Therapy, 34, 207, 10.1080/16506070510010684 · DOI · Paper page
- Swanson, 1999, Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients, Journal of Nervous and Mental Disease, 187, 630, 10.1097/00005053-199910000-00007 · DOI · Paper page
- Tracy, 2007, Contingency management to reduce substance use in individuals who are homeless with co-occurring psychiatric disorders, American Journal of Drug and Alcohol Abuse, 33, 253, 10.1080/00952990601174931 · DOI · Paper page
- Audier, 2011, Money for medication: A randomized controlled study on the effectiveness of financial incentives to improve medication adherence in patients with a psychotic disorder and co-morbid substance abuse, Schizophrenia Bulletin, 1, 294
- Bachmann, 1997, An integrated treatment program for dually diagnosed patients, Psychiatric Services, 48, 314, 10.1176/ps.48.3.314 · DOI
- Bagoien, 2011, Motivational interviewing to patients with comorbid substance use admitted to an acute psychiatric department, Psychiatrische Praxis, 38, S10, 10.1055/s-0031-1277785 · DOI
- Bagoien, 2013, The effects of motivational interviewing on patients with comorbid substance use admitted to a psychiatric emergency unit - a randomised controlled trial with two year follow-up, BMC Psychiatry, 13, 93, 10.1186/1471-244X-13-93 · DOI · Paper page
- Barrowclough, 2006, Group cognitive-behavioural therapy for schizophrenia, British Journal of Psychiatry, 189, 527, 10.1192/bjp.bp.106.021386 · DOI · Paper page
- Beebe, 2012, Motivational intervention increases exercise in schizophrenia and co-occurring substance use disorders, Schizophrenia Research, 135, 204, 10.1016/j.schres.2011.12.008 · DOI
- Bell, 2011, Cognitive remediation with work therapy in the initial phase of substance abuse treatment, Schizophrenia Bulletin, Suppl 1, 296
- Bennett, 2001, Treating substance abuse in schizophrenia: An initial report, Journal of Substance Abuse Treatment, 20, 163, 10.1016/S0740-5472(00)00167-7 · DOI
- Berk, 1999, A comparison of olanzapine with haloperidol in cannabis-induced psychotic disorder: a double-blind randomised controlled trial, International Clinical Psychopharmacology, 14, 177, 10.1097/00004850-199905030-00005 · DOI
- Biegel, 2009, Predictors of referral to supported employment among consumers with co-occurring mental and substance use disorders, Community Mental Health Journal, 45, 427, 10.1007/s10597-009-9242-3 · DOI
- Bowen, 2000, A controlled trial of cognitive behavioural treatment of panic in alcoholic inpatients with comorbid panic disorder, Addictive Behaviours, 25, 593, 10.1016/S0306-4603(99)00017-9 · DOI
- Caplan, 2006, Change in neurocognition by housing type and substance abuse among formerly homeless seriously mentally ill persons, Schizophrenia Research, 83, 77, 10.1016/j.schres.2005.11.013 · DOI
- Carey, 2001, Enhancing readiness-to-change substance abuse in persons with schizophrenia. A four-session motivation-based intervention, Behaviour Modification, 25, 331, 10.1177/0145445501253001 · DOI
- Carey, 2004, Reducing HIV-risk behavior among adults receiving outpatient psychiatric treatment: Results from a randomized controlled trial, Journal of Consulting and Clinical Psychology, 72, 252, 10.1037/0022-006X.72.2.252 · DOI · Paper page
- Carroll, 1991, A comparative trial of psychotherapies for ambulatory cocaine abusers: relapse prevention and interpersonal psychotherapy, American Journal of Drug and Alcohol Abuse, 17, 229, 10.3109/00952999109027549 · DOI · Paper page
- Carroll, 1998, Managing MICA clients in a modified therapeutic community with enhanced staffing, Journal of Substance Abuse Treatment, 15, 565, 10.1016/S0740-5472(98)00005-1 · DOI
- Ceron D Mondoni S Malbergier A Silva G Schizophrenia: the influence of acupuncture on cocaine addicted patients Conference presentation to 153rd Annual Meeting of the APA, May 13-18, Chicago 2000
- Cheng, 2007, Impact of supported housing on clinical outcomes: analysis of a randomized trial using multiple imputation technique, Journal of Nervous and Mental Disease, 195, 83, 10.1097/01.nmd.0000252313.49043.f2 · DOI · Paper page
- Clark, 2001, Family support and substance use outcomes for persons with mental illness and substance use disorders, Schizophrenia Bulletin, 27, 93, 10.1093/oxfordjournals.schbul.a006862 · DOI · Paper page
- Conrad, 2006, randomized trial of psychiatric care with representative payeeship for persons with serious mental illness, Psychiatric Services, 57, 197, 10.1176/appi.ps.57.2.197 · DOI
- Craig, 2008, Integrated care for co-occurring disorders: psychiatric symptoms, social functioning, and service costs at 18 months, Psychiatric Services, 59, 276, 10.1176/ps.2008.59.3.276 · doi:10.1176/ps.2008.59.3.276 · Paper page
- Crump, 1996, The efficacy of substance abuse education among dual-diagnosis patients, Journal of Substance Abuse Treatment, 13, 141, 10.1016/0740-5472(96)00042-6 · doi:10.1016/0740-5472(96)00042-6
- D'Ercole, 1997, Effects of diagnosis, demographic characteristics, and case management on rehospitalization, Psychiatric Services, 48, 682, 10.1176/ps.48.5.682 · DOI
- Dalack, 1999, Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia, Neuropsychopharmacology, 21, 195, 10.1016/S0893-133X(98)00121-3 · DOI
- Daley, 1998, Increasing treatment adherence among outpatients with depression and cocaine dependence: Results of a pilot study, American Journal of Psychiatry, 155, 1611, 10.1176/ajp.155.11.1611 · DOI · Paper page
- DeMarce, 2008, Promoting continuing care adherence among substance abusers with co-occurring psychiatric disorders following residential treatment, Addictive Behaviors, 33, 1104, 10.1016/j.addbeh.2008.02.008 · DOI
- Drake, 2004, Three-year outcomes of long-term patients with co-occurring bipolar and substance use disorders, Biological Psychiatry, 56, 749, 10.1016/j.biopsych.2004.08.020 · DOI
- Drake, 2006, Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders, Schizophrenia Bulletin., 32, 464, 10.1093/schbul/sbj064 · DOI · Paper page
- Drebing, 2005, The impact of enhanced incentives on vocational rehabilitation outcomes for dually diagnosed veterans, Journal of Applied Behavior Analysis, 38, 359, 10.1901/jaba.2005.100-03 · DOI · Paper page
- Drebing, 2007, Adding contingency management intervention to vocational rehabilitation: outcomes for dually diagnosed veterans, Journal of Rehabilitation Research and Development, 44, 851, 10.1682/JRRD.2006.09.0123 · DOI
- Eberhard, 2009, Secondary prevention of hazardous alcohol consumption in psychiatric out-patients: a randomised controlled study, Social Psychiatry and Psychiatric Epidemiology, 12, 1013, 10.1007/s00127-009-0023-7 · DOI
- Essock, 1995, Implementing assertive community treatment teams, Psychiatric Services, 46, 679, 10.1176/ps.46.7.679 · DOI · Paper page
- Faber, 2012, Continued cannabis use and outcome in first-episode psychosis: Data from a randomized, open-label, controlled trial, Journal of Clinical Psychiatry, 73, 632, 10.4088/JCP.11m07069 · DOI · Paper page
- Fisher, 1996, Two group therapy models for clients with a dual diagnosis of substance abuse and personality disorder, Psychiatric Services, 47, 1244, 10.1176/ps.47.11.1244 · DOI
- Leon, 2000, Modified therapeutic community for homeless mentally ill chemical abusers: treatment outcomes, American Journal of Drug and Alcohol Abuse, 26, 461, 10.1081/ADA-100100256 · DOI
- French, 1999, Modified therapeutic community for mentally ill chemical abusers: outcomes and costs, Evaluation and the Health Professions, 22, 60, 10.1177/016327879902200104 · DOI
- Giannini, 2000, Acute ketamine intoxication treated by haloperidol: a preliminary study, American Journal of Therapeutics, 7, 389, 10.1097/00045391-200007060-00008 · DOI
- Godley, 2000, Case management for dually diagnosed individuals involved in the criminal justice system, Journal of Substance Abuse Treatment, 18, 137, 10.1016/S0740-5472(99)00027-6 · DOI
- Goldstein, 2005, Rehabilitation during alcohol detoxication in comorbid neuropsychiatric patients, Journal of Rehabilitation Research and Development, 42, 225, 10.1682/JRRD.2004.03.0040 · DOI
- Havassy, 2000, Effects of substance dependence on outcomes of patients in a randomized trial of two case management models, Psychiatric Services, 51, 639, 10.1176/appi.ps.51.5.639 · DOI · Paper page
- Hayes, 2003, Service enhancement to a dual-diagnosis population: Mental Illness/Substance Abuse (MISA), Quality Management in Health Care, 12, 133, 10.1097/00019514-200307000-00004 · DOI
- Hien, 2004, Promising treatment for women with comorbid PTSD and substance use disorders, American Journal of Psychiatry, 161, 1426, 10.1176/appi.ajp.161.8.1426 · DOI · Paper page
- Herman, 1997, Immediate outcomes of substance abuse treatment within a state psychiatric hospital, Journal of Mental Health Administration, 24, 126, 10.1007/BF02898508 · DOI
- Herman, 2000, Longitudinal effects of integrated treatment on alcohol use for persons with serious mental illness and substance use disorders, Journal of Behavioral Health Services and Research, 27, 286, 10.1007/BF02291740 · DOI
- Hulse, 2002, Six-month outcomes associated with a brief alcohol intervention for adult in-patients with psychiatric disorders, Drug and Alcohol Review, 21, 105, 10.1080/09595230220138993a · DOI · Paper page
- Hurlburt, 1996, Effects of substance abuse on housing stability of homeless mentally ill persons in supported housing, Psychiatric Services, 47, 731, 10.1176/ps.47.7.731 · DOI · Paper page
- James, 2004, A group intervention which assists patients with dual diagnosis reduce their drug use: a randomized controlled trial, Psychological Medicine, 34, 983, 10.1017/S0033291703001648 · DOI · Paper page
- Jerrell, 2000, Issues and outcomes in integrated treatment programs for dual disorders, Journal of Behavioral Health Services & Research, 27, 303, 10.1007/BF02291741 · DOI
- Jones, 2011, Integrated motivational interviewing and cognitive-behavioural therapy for bipolar disorder with comorbid substance use, Clinical Psychology & Psychotherapy, 18, 426, 10.1002/cpp.783 · DOI
- Judd, 2003, A dual diagnosis demonstration project: treatment outcomes and cost analysis, Journal of Psychoactive Drugs, 35 Suppl 1, 181, 10.1080/02791072.2003.10400513 · DOI
- Kasprow, 1999, Residential treatment for dually diagnosed homeless veterans: a comparison of program types, American Journal on Addictions, 8, 34, 10.1080/105504999306063 · DOI
- Keet, 2006, Family motivational intervention: training motivational interviewing for family members of patients with schizophrenia, cannabis use and poor compliance, Schizophrenia Research, 86 Suppl 1, S149, 10.1016/S0920-9964(06)70445-5 · doi:10.1016/s0920-9964(06)70445-5
- Kelly, 2003, Major depression in patients with substance use disorders: relationship to 12-step self-help involvement and substance use outcomes, Addiction, 98, 499, 10.1046/j.1360-0443.2003.t01-1-00294.x · DOI · Paper page
- Lasser, 2000, The unique aspects of the realise program - a global development programme to assess the safety, efficacy and long-term impact of iloperidone in schizophrenia, International Journal of Neuropsychopharmacology, 3, S123
- Magura, 2003, Role of self-help processes in achieving abstinence among dually diagnosed persons, Addictive Behaviours, 28, 399, 10.1016/S0306-4603(01)00278-7 · DOI
- Martino, 2000, Motivational interviewing with psychiatrically ill substance abusing patients, The American Journal on Addictions, 9, 88, 10.1080/10550490050172263 · DOI · Paper page
- Martino, 2006, A randomized controlled pilot study of motivational interviewing for patients with psychotic and drug use disorders, Addiction, 101, 1479, 10.1111/j.1360-0443.2006.01554.x · DOI · Paper page
- McGeary, 2000, Service use and cost by mentally ill chemical abusers: differences by retention in a therapeutic community, Journal of Substance Abuse, 11, 265, 10.1016/S0899-3289(00)00026-2 · DOI
- McGurk, 2009, Work, recovery, and comorbidity in schizophrenia: a randomized controlled trial of cognitive remediation, Schizophrenia Bulletin, 35, 319, 10.1093/schbul/sbn182 · DOI · Paper page
- McHugo, 1999, Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study, Psychiatric Services, 50, 818, 10.1176/ps.50.6.818 · DOI · Paper page
- Mercer McFadden, 1997, The Community Support Program demonstrations of services for young adults with severe mental illness and substance use disorders, 1987-1991, Psychiatric Rehabilitation Journal, 20, 13, 10.1037/h0095368 · DOI
- Milby, 2000, Initiating abstinence in cocaine abusing dually diagnosed homeless persons, Drug & Alcohol Dependence, 60, 55, 10.1016/S0376-8716(00)80008-3 · DOI
- Mowbray, 1999, Analysis of postdischarge change in a dual diagnosis population, Health and Social Work, 24, 91, 10.1093/hsw/24.2.91 · DOI
- Mueser, 2001, Rural and urban differences in patients with a dual diagnosis, Schizophrenia Research, 48, 93, 10.1016/S0920-9964(00)00065-7 · DOI
- Mueser, 2009, Family intervention for co-occurring substance use and severe psychiatric disorders: participant characteristics and correlates of initial engagement and more extended exposure in a randomized controlled trial, Addictive Behaviors, 34, 867, 10.1016/j.addbeh.2009.03.025 · DOI · Paper page
- Mueser, 2010, Family psychoeducation with patients who have co-occurring substance use disorders and severe mental illness, Schizophrenia Research, 117, 121, 10.1016/j.schres.2010.02.059 · DOI
- Mueser, 2013, A randomized controlled trial of family intervention for co-occurring substance use and severe psychiatric disorders, Schizophrenia Bulletin, 39, 658, 10.1093/schbul/sbr203 · DOI · Paper page
- Nuijten, 2012, A randomised controlled trial of outpatient versus inpatient integrated treatment of dual diagnosis patients: A failed but informative study, Mental Health and Substance Use: Dual Diagnosis, 5, 132, 10.1080/17523281.2011.628947 · DOI
- Nuttbrock, 1997, Pre- and post-admission attrition of homeless, mentally ill chemical abusers referred to residential treatment programs, Addiction, 92, 1305, 10.1111/j.1360-0443.1997.tb02849.x · DOI
- Nuttbrock, 1998, Outcomes of homeless mentally ill chemical abusers in community residences and a therapeutic community, Psychiatric Services, 49, 68, 10.1176/ps.49.1.68 · DOI · Paper page
- Rahav, 1995, Characteristics and treatment of homeless, mentally ill, chemical-abusing men, Journal of Psychoactive Drugs, 27, 93, 10.1080/02791072.1995.10471677 · DOI
- Otto-Salaj, 2001, Outcomes of a randomized small-group HIV prevention intervention trial for people with serious mental illness, Community Mental Health Journal, 37, 123, 10.1023/A:1002709715201 · DOI
- Brooks, 2003, Comparing treatments for dual diagnosis: Twelve-step and self-management and recovery training, The American Journal of Drug and Alcohol Abuse, 29, 359, 10.1081/ADA-120020519 · DOI · Paper page
- Penn, 2000, Five years, twelve steps, and REBT in the treatment of dual diagnosis, Journal of Rational-Emotive & Cognitive-Behavior Therapy, 18, 197, 10.1023/A:1007883021936 · DOI
- Petersen, 2006, Substance abuse in first-episode schizophrenia-spectrum disorders, Schizophrenia Research, 86 Suppl 1, S44, 10.1016/S0920-9964(06)70132-3 · DOI
- Petersen, 2007, Does cannabis abuse determine outcome among patients with first episode psychosis. Results from the OPUS-trial, Schizophrenia Bulletin, 33, 453
- Rahav, 1995, Characteristics and treatment of homeless, mentally ill, chemical-abusing men, Journal of Psychoactive Drugs, 27, 93, 10.1080/02791072.1995.10471677 · DOI
- Ries, 2004, Outcomes of managing disability benefits among patients with substance dependence and severe mental illness, Psychiatric Services, 55, 445, 10.1176/appi.ps.55.4.445 · DOI · Paper page
- Rosenheck, 1998, Cost-effectiveness of intensive psychiatric community care for high users of inpatient services, Archives of General Psychiatry, 55, 459, 10.1001/archpsyc.55.5.459 · DOI · Paper page
- Sacks, 2004, Modified TC for MICA offenders: crime outcomes, Behavioral Sciences and the Law, 22, 477, 10.1002/bsl.599 · DOI · Paper page
- Sacks, 2008, Prison therapeutic community treatment for female offenders: profiles and preliminary findings for mental health and other variables (crime, substance use and HIV risk), Journal of Offender Rehabilitation, 46, 233, 10.1080/10509670802143680 · DOI · Paper page
- Sullivan, 2007, Modified therapeutic community treatment for offenders with MICA disorders: substance use outcomes, American Journal of Drug and Alcohol Abuse, 33, 823, 10.1080/00952990701653800 · DOI · Paper page
- Samele, 2002, Non-alcohol substance misuse, outcome and intensive case management, European Psychiatry, 17 Suppl 1, 216s, 10.1016/S0924-9338(02)80923-3 · DOI
- Santa Ana, 2007, Efficacy of group motivational interviewing (GMI) for psychiatric inpatients with chemical dependence, Journal of Consulting and Clinical Psychology, 75, 816, 10.1037/0022-006X.75.5.816 · DOI
- Schaar, 2001, Severely mentally ill substance abusers: an 18 month follow-up study, Social Psychiatry Psychiatric Epidemiology, 36, 70, 10.1007/s001270170066 · DOI
- Schmitz, 2002, Cognitive-behavioral treatment of bipolar disorder and substance abuse: A preliminary randomized study, Addictive Disorders and Their Treatment, 1, 17, 10.1097/00132576-200205000-00004 · DOI · Paper page
- Sigmon, 2000, Contingent reinforcement of marijuana abstinence among individuals with serious mental illness: a feasibility study, Experimental & Clinical Psychopharmacology, 8, 509, 10.1037/1064-1297.8.4.509 · doi:10.1037/1064-1297.8.4.509 · Paper page
- Siris, 1993, Adjunctive imipramine in substance-abusing dysphoric schizophrenic patients, Psychopharmacology Bulletin, 29, 127
- Sitharthan, 1999, Integrated drug and alcohol intervention: development of an opportunistic intervention program to reduce alcohol and other substance use among psychiatric patients, Australian and New Zealand Journal of Psychiatry, 33, 676, 10.1080/j.1440-1614.1999.00621.x · DOI
- Smeerdijk M Keet R De Haan L Schippers G Linszen D Family motivation intervention in early onset psychosis and cannabis abuse: a randomized clinical trial Proceedings of the 12th International Congress on Schizophrenia Research; 2009 Mar 28-Apr 1; San Diego, CA Oxford Univ Press 371
- Smeerdijk, 2010, Motivational interviewing and interaction skills training for parents to change cannabis use in young adults with recent onset schizophrenia, Early Intervention in Psychiatry, 4 Suppl 1, 6
- Smeerdijk, 2012, Motivational interviewing and interaction skills training for parents to change cannabis use in young adults with recent-onset schizophrenia: a randomized controlled trial, Psychological Medicine, 42, 1627, 10.1017/S0033291711002832 · DOI
- Swanson, 2000, Involuntary out-patient commitment and reduction of violent behaviour in persons with severe mental illness, British Journal of Psychiatry, 176, 324, 10.1192/bjp.176.4.324 · DOI · Paper page
- Teague, 1995, Evaluating use of continuous treatment teams for persons with mental illness and substance abuse, Psychiatric Services, 46, 689, 10.1176/ps.46.7.689 · DOI · Paper page
- Hughes, 2008, Training in dual diagnosis interventions (the COMO Study): randomised controlled trial, BMC Psychiatry, 8, 12, 10.1186/1471-244X-8-12 · DOI · Paper page
- Johnson, 2007, Effects of training community staff in interventions for substance misuse in dual diagnosis patients with psychosis (COMO study): cluster randomised trial, British Journal of Psychiatry, 191, 451, 10.1192/bjp.bp.106.032367 · DOI
- Timko, 2006, Dual diagnosis patients in community or hospital care: one-year outcomes and health care utilization and costs, Journal of Mental Health, 15, 163, 10.1080/09638230600559631 · DOI
- Timko, 2004, Short-term outcomes of matching dual diagnosis patients' symptom severity to treatment intensity, Journal of Substance Abuse Treatment., 26, 209, 10.1016/S0740-5472(04)00002-9 · DOI
- Tyrer, 2011, Nidotherapy in the treatment of substance misuse, psychosis and personality disorder: Secondary analysis of a controlled trial, Psychiatrist, 35, 9, 10.1192/pb.bp.110.029983 · DOI
- Watt, 2006, Brief CBT for high anxiety sensitivity decreases drinking problems, relief alcohol outcome expectancies, and conformity drinking motives: evidence from a randomized controlled trial, Journal of Mental Health, 15, 683, 10.1080/09638230600998938 · DOI · Paper page
- Weaver, 2009, Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders, Journal of Mental Health Policy and Economics, 12, 33
- Weiss, 2000, Group therapy for patients with bipolar disorder and substance dependence: results of a pilot study, Journal of Clinical Psychiatry, 61, 361, 10.4088/JCP.v61n0507 · DOI · Paper page
- Worley, 2010, Service utilization during and after outpatient treatment for comorbid substance use disorder and depression, Journal of Substance Abuse Treatment, 39, 124, 10.1016/j.jsat.2010.05.009 · DOI
- Xie, 2005, Substance abuse relapse in a ten-year prospective follow-up of clients with mental and substance use disorders, Psychiatric Services, 56, 1282, 10.1176/appi.ps.56.10.1282 · DOI · Paper page
- Xie, 2005, Three-year recovery outcomes for long-term patients with co-occurring schizophrenic and substance use disorders, Schizophrenia Research, 75, 337, 10.1016/j.schres.2004.07.012 · DOI
- Xie, 2006, Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group-based modeling approach, Administration and Policy in Mental Health and Mental Health Services, 33, 423, 10.1007/s10488-006-0048-0 · DOI
- Meister, 2010, A cluster-randomized, parallel group, observer blind trial of a group based motivational-behavioural therapy for young people with psychosis and substance use disorder, Early Intervention in Psychiatry, 4 Suppl 1, 163
- Meister K Comorbid psychosis and addiction. Epidemiology, explanatory models and evaluation of motivational behavioural group therapy Dissertation, University of Hamburg 2010
- Odom, 2005, A randomized study of integrated outpatient treatment and assertive community treatment for patients with comorbid mental illness and substance use disorders: comparing treatment outcome for domiciled and homeless patients [PhD thesis]
- Bennett, 2007, Treatment of alcohol use disorders in people with severe mental illness, Schizophrenia Bulletin, 33, 421
- Bennett, 2011, The effects of a group based behavioral approach to substance misuse and schizophrenia, Schizophrenia Bulletin, 1, 296
- Smith S Greenwood K Atakan Z Sood P Ohlsen R Papanastasiou E The impact study - motivating a change in health behaviour European Psychiatry 2011 · DOI
- Barrowclough, 2010, Helper recap: Rethinking choices after psychosis - a phase specific psychological therapy for people with problematic cannabis use following a first episode of psychosis, Early Intervention in Psychiatry, 4 Suppl 1, 161
- Worrell L Helper programme (substance misuse)- a phase-specific psychological therapy for people with problematic cannabis use following a first episode of psychosis (recap) http://public.ukcrn.org.uk 2011 · DOI
- Altman, 2001, The revised CONSORT statement for reporting randomized trial: explanation and elaboration, Annals of Internal Medicine, 134, 663, 10.7326/0003-4819-134-8-200104170-00012 · DOI · Paper page
- Appleby, 1997, Assessing substance use in multiproblem patients: reliability and validity of the Addiction Severity Index in a mental hospital population, Journal of Nervous & Mental Disease, 185, 159, 10.1097/00005053-199703000-00005 · DOI · Paper page
- Asberg, 1978, A comprehensive psychopathological rating scale, Acta Psychiatrica Scandinavica Supplement, 271, 5, 10.1111/j.1600-0447.1978.tb02357.x · DOI · Paper page
- Baker, 2012, A systematic review of psychological interventions for excessive alcohol consumption among people with psychotic disorders, Acta Psychiatrica Scandinavica, 126, 243, 10.1111/j.1600-0447.2012.01885.x · DOI · Paper page
- Barrowclough, 2006, Treatment development for psychosis and co-occurring substance misuse: A descriptive review, Journal of Mental Health, 15, 619, 10.1080/09638230600998920 · DOI
- Beck, 1972, Screening depressed patients in family practice. A rapid technique, Postgraduate Medicine, 52, 81, 10.1080/00325481.1972.11713319 · DOI · Paper page
- Birchwood, 1990, The Social Functioning Scale: the development and validation of a scale of social adjustment for use in family intervention programmes with schizophrenic patients, British Journal of Psychiatry, 157, 853, 10.1192/bjp.157.6.853 · DOI · Paper page
- Bland, 1997, Trials randomised in clusters, BMJ, 315, 600, 10.1136/bmj.315.7108.600 · DOI · Paper page
- Bogenschutz, 2006, The role of twelve-step approaches in dual diagnosis treatment and recovery, American Journal on Addictions, 15, 50, 10.1080/10550490500419060 · DOI
- Boissel, 1999, The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use, Therapie, 54, 405
- Bond, 1988, Assertive case management in three CMHCs: a controlled study, Hospital and Community Psychiatry, 39, 411
- Bond, 1990, Assertive community treatment for frequent users of psychiatric hospitals in a large city: a controlled study, American Journal of Community Psychology, 18, 865, 10.1007/BF00938068 · DOI · Paper page
- Burns, 2007, Social functioning as an outcome measure in schizophrenia studies, Acta Psychiatrica Scandinavica, 116, 403, 10.1111/j.1600-0447.2007.01108.x · DOI · Paper page
- Carey, 1996, Concurrent validity of clinicians' rating of substance abuse among psychiatric outpatients, Psychiatric Services, 47, 842, 10.1176/ps.47.8.842 · DOI · Paper page
- Carra, 2009, Variations in rates of comorbid substance use in psychosis between mental health settings and geographical areas in the UK. A systematic review, Social Psychiatry & Psychiatric Epidemiology, 44, 429, 10.1007/s00127-008-0458-2 · DOI
- Chanut, 2005, Motivational interviewing and clinical psychiatry, Canadian Journal of Psychiatry, 50, 548, 10.1177/070674370505000908 · DOI · Paper page
- Cleary, 2009, Psychosocial treatments for people with co-occurring severe mental illness and substance misuse: systematic review, Journal of Advanced Nursing, 65, 238, 10.1111/j.1365-2648.2008.04879.x · DOI · Paper page
- Cleary, 2009, Conducting efficient literature searches. Strategies for mental health nurses, Journal of Psychosocial Nursing & Mental Health Services, 47, 34, 10.3928/02793695-20090930-03 · DOI
- Corse, 1995, The use of the Addiction Severity Index with people with severe mental illness, Psychiatric Rehabilitation Journal, 19, 9, 10.1037/h0095465 · DOI
- Darke, 1991, The Opiate Treatment Index (OTI) Researchers Manual. Technical report No. 11
- Darke, 1992, Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index, British Journal of Addiction, 87, 733, 10.1111/j.1360-0443.1992.tb02719.x · DOI · Paper page
- David, 1992, The assessment of insight in psychosis, British Journal of Psychiatry, 161, 599, 10.1192/bjp.161.5.599 · DOI · Paper page
- Derogatis, 1973, SCL-90: An outpatient psychiatric rating scale: Preliminary report, Psychopharmacology Bulletin, 9, 13
- Derogatis, 1975, Social class, psychological disorder, and the nature of the psychpathologic indicator, Journal of Consulting and Clinical Psychology, 43, 183, 10.1037/h0076514 · DOI
200 of 272 shown
Cited by
Lai, H. M. X., Cleary, M., Sitharthan, T., & Hunt, G. E. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.05.031 · Cited by 941
Self-citationGalletly, C., Castle, D., Dark, F., Humberstone, V., Jablensky, A., Killackey, E., Kulkarni, J., McGorry, P., Nielssen, O., & Tran, N. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416641195 · Cited by 877
Hunt, G. E., Large, M. M., Cleary, M., Lai, H. M. X., & Saunders, J. B. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.07.011 · Cited by 482
Self-citationConnor, J. P., Haber, P. S., & Hall, W. D. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00122-1 · Cited by 389
Psychosocial interventions for self-harm in adults
Hawton, K., Witt, K. G., Taylor Salisbury, T. L., Arensman, E., Gunnell, D., Hazell, P., Townsend, E., & van Heeringen, K. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012189 · Cited by 310
Cooper, S. J., Reynolds, G. P., order):, W. E. C.-A. (. A., Barnes, T., England, E., Haddad, P., Heald, A., Holt, R., Lingford-Hughes, A., Osborn, D., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116645254 · Cited by 292
Interventions for self-harm in children and adolescents
Hawton, K., Witt, K. G., Taylor Salisbury, T. L., Arensman, E., Gunnell, D., Townsend, E., van Heeringen, K., & Hazell, P. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012013 · Cited by 261
Bickman, L. (2020) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-020-01065-8 · Cited by 184
Interventions for self-harm in children and adolescents
Witt, K. G., Hetrick, S. E., Rajaram, G., Hazell, P., Taylor Salisbury, T. L., Townsend, E., & Hawton, K. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013667.pub2 · Cited by 149
Savic, M., Best, D., Manning, V., & Lubman, D. I. (2017) · Substance Abuse Treatment, Prevention, and Policy · doi:10.1186/s13011-017-0104-7 · Cited by 125
Psychosocial interventions for people with both severe mental illness and substance misuse
Hunt, G. E., Siegfried, N., Morley, K., Brooke-Sumner, C., & Cleary, M. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001088.pub4 · Cited by 105
Self-citationA Review of Integrated Care for Concurrent Disorders: Cost Effectiveness and Clinical Outcomes
Karapareddy, V. (2019) · Journal of Dual Diagnosis · doi:10.1080/15504263.2018.1518553 · Cited by 77
Integrating Treatment for Co-Occurring Mental Health Conditions
Yule, A. (2019) · Alcohol Research: Current Reviews · doi:10.35946/arcr.v40.1.07 · Cited by 63
Tran, M. T. N., Luong, Q. H., Le Minh, G., Dunne, M. P., & Baker, P. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.512076 · Cited by 42
“Previous systematic reviews identified low-quality evidence of reducing drug use (37), increasing mental health (57), reducing injection and sexual risk behaviour.”
BackgroundPadmanathan, P., Hall, K., Moran, P., Jones, H. E., Gunnell, D., Carlisle, V., Lingford-Hughes, A., & Hickman, M. (2020) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2019.152135 · Cited by 41
Preusse, M., Neuner, F., & Ertl, V. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00768 · Cited by 38
Berry, K., Gregg, L., Lobban, F., & Barrowclough, C. (2016) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2016.02.014 · Cited by 32
“Participants in the brief intervention condition were offered up to 12 sessions of MICBT over 4.5 months and participants in the long-term intervention condition were offered up to 24 sessions over 9 months.”
BackgroundMethodInfluentialPsychosocial Interventions in Patients with Dual Diagnosis
Subodh, B., Sharma, N., & Shah, R. (2018) · Indian Journal of Psychiatry · doi:10.4103/psychiatry.indianjpsychiatry_18_18 · Cited by 22
Metadata
- Authors
- Hunt, G. E., Siegfried, N., Morley, K., Sitharthan, T., & Cleary, M.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2013-10-03
- Issue
- 10
- Pages
- CD001088-CD001088
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W4236645313
- Cited by
- 116
- References
- 53
- FWCI
- 10.81
- Type
- journal article
- Language
- en
- Update notices
- new_version (2019-12-12)
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.